pregnant women

  • The DELIVER and B-PROTECTED Studies: Preventing HIV in Pregnant and Breastfeeding

    Knowing whether daily oral pre-exposure prophylaxis (PrEP) and use of the monthly dapivirine ring are safe during pregnancy and breastfeeding is vitally important. This fact sheet provides background on two studies that will address these questions.

  • MTN–042 – DELIVER

    Links are provided to information about the DELIVER study, which is evaluating the safety and acceptability of the use of a monthly dapivirine ring or a daily antiretroviral pill (FTC/TDF, or Truvada) during pregnancy.

  • - Private group -

    MNCH/PMTCT Communication Strategy

    CCP developed this Maternal, Neonatal and Child Health (MNCH)/Prevention of Mother-to-Child Transmission (PMTCT) communication strategy in 2011.